BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2701315)

  • 1. Comparison of the behavioral effects and abuse liability of ethanol and pentobarbital in recreational sedative abusers.
    Guarino JJ; Roache JD; Kirk WT; Griffiths RR
    NIDA Res Monogr; 1989; 95():453-4. PubMed ID: 2701315
    [No Abstract]   [Full Text] [Related]  

  • 2. Zolpidem and triazolam in humans: behavioral effects and abuse liability.
    Evans SM; Griffiths RR
    NIDA Res Monogr; 1989; 95():431-2. PubMed ID: 2701312
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fluvoxamine, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
    Linnoila M; Stapleton JM; George DT; Lane E; Eckardt MJ
    J Clin Psychopharmacol; 1993 Jun; 13(3):175-80. PubMed ID: 8354733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers.
    Mintzer MZ; Guarino J; Kirk T; Roache JD; Griffiths RR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):203-15. PubMed ID: 9260068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective effects of methaqualone.
    Ionescu-Pioggia M; Bird M; Cole JO
    NIDA Res Monogr; 1989; 95():455. PubMed ID: 2701316
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental assessment of the relative abuse liability of triazolam and pentobarbital.
    Roache JD; Griffiths RR
    NIDA Res Monogr; 1984; 55():106-10. PubMed ID: 6443368
    [No Abstract]   [Full Text] [Related]  

  • 8. Human psychopharmacology of intranasal cocaine.
    Higgins ST; Hughes JR; Bickel WK
    NIDA Res Monogr; 1989; 95():357-8. PubMed ID: 2701303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considering the psychotropic effect of alcohol].
    von Wartburg JP
    Ther Umsch; 1990 May; 47(5):399-404. PubMed ID: 2195700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response to alcohol in light and moderate female social drinkers.
    Evans SM; Levin FR
    Behav Pharmacol; 2004 May; 15(3):167-81. PubMed ID: 15187575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference for ethanol in males with or without an alcoholic first degree relative.
    de Wit H; McCracken SG
    NIDA Res Monogr; 1989; 95():374-5. PubMed ID: 2701305
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the abuse potential of the novel analgesic flupirtine maleate.
    Preston KL; Funderburk FR; Liebson IA; Bigelow GE
    Drug Alcohol Depend; 1991 Mar; 27(2):101-13. PubMed ID: 2055157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of alprazolam in chronic therapeutic users.
    Lucki I; Kerr LA; Fridman RB; Schweizer E; Rickels K
    NIDA Res Monogr; 1989; 95():464. PubMed ID: 2701317
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of prostaglandin synthesis and effects of ethanol and pentobarbital in humans.
    Pickworth WB; Fant RV; Henningfield JE
    J Pharmacol Exp Ther; 1997 Oct; 283(1):274-80. PubMed ID: 9336333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.